US Patent Issued to Neurovation Labs on April 15 for "Compositions and methods to detect GLUA1 in brain and to identify the presence of GLUA1-mediated PTSD" (New York Inventor)

ALEXANDRIA, Va., June 5 -- United States Patent no. 12,274,761, issued on April 15, was assigned to Neurovation Labs Inc. (New York).

"Compositions and methods to detect GLUA1 in brain and to identify the presence of GLUA1-mediated PTSD" was invented by Jennifer Perusini (New York).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides compositions and methods for detecting GluA1, as a subunit protein and/or as a GluA1-containing, GluA2-lacking AMPAR complex. The invention further provides composition and methods for detecting and/or diagnosing PTSD. The invention further relates to compositions that can be detected using radiological imaging techniques, and processes for performing suc...